Relationship Between Human Papilloma Virus and Benignand Malign Lesions of Oral Cavity and Oropharynx,Current Approach

Papillomavirus enfeksiyonu insanlarda çok sık görülen ve esas olarak cinsel yolla bulaşan bir hastalıktır. HPV enfeksiyonunun gelişimi, uterus serviksi, diğer alt genital bölge mukozası ve oral mukozadan başlayabilir. HPV subklinik veya klinik enfeksiyonlara neden olabilir. HPV ile ilişkili klinik enfeksiyonlar, genital papillomlar, cilt papillomları, nükseden solunum yolu papillomatozisi, skuamöz intraepitelyal lezyonlar ve serviks, oral kavite ve orofarinks kanseridir. Oral kanserlerin yaklaşık %20'si ve orofaringeal kanserlerin %60-80'inin HPV enfeksiyonuna bağlı olabileceği düşünülmektedir. 2007'de birçok Avrupa ülkesinde HPV aşısının kullanıma sunulmasından bu yana 40'dan fazla ülke, ulusal bağışıklama programlarında HPV aşılamayı başlattı. Orofarengeal ve Oral kavite kanser tedavisinden sorumlu hekimler, HPV aşısı hakkında bilgi sahibi olmalı ve HPV ile ilişkili enfeksiyon ve kanserleri azaltmak için teknolojideki gelişmeleri takip etmelidir.Papillomavirus infection is a very common and mainly sexually transmitted disease in humans. The development of HPV infection may start from uterine cervix, other lower genital area mucosa and oral mucosa. HPV can cause subclinical or clinical infections. Clinical infections associated with HPV are genital papillomas, skin papillomas, recurrent respiratorial papilomatosis, intraepithelial squamous lesions, cervix, oral cavity and oropharyngeal cancer. Approximately 20% of oral cancers and 60-80% of oropharyngeal cancers are thought to be due to HPV infection. Since the introduction of HPV vaccine in many European countries in 2007, more than 40 countries have launched HPV vaccination in national immunization programs. Physicians responsible for the treatment of oropharyngeal and oral cavity cancer should be knowledgeable about HPV vaccination and should follow developments in technology to reduce HPV-associated infections and cancers

Relationship between human papilloma virus and benign and malign lesions of oral cavity and oropharynx, current approach

Papillomavirus enfeksiyonu insanlarda çok sık görülen ve esas olarak cinsel yolla bulaşan bir hastalıktır. HPV enfeksiyonunun gelişimi, uterus serviksi, diğer alt genital bölge mukozası ve oral mukozadan başlayabilir. HPV subklinik veya klinik enfeksiyonlara neden olabilir. HPV ile ilişkili klinik enfeksiyonlar, genital papillomlar, cilt papillomları, nükseden solunum yolu papillomatozisi, skuamöz intraepitelyal lezyonlar ve serviks, oral kavite ve orofarinks kanseridir. Oral kanserlerin yaklaşık %20'si ve orofaringeal kanserlerin %60-80'inin HPV enfeksiyonuna bağlı olabileceği düşünülmektedir. 2007'de birçok Avrupa ülkesinde HPV aşısının kullanıma sunulmasından bu yana 40'dan fazla ülke, ulusal bağışıklama programlarında HPV aşılamayı başlattı. Orofarengeal ve Oral kavite kanser tedavisinden sorumlu hekimler, HPV aşısı hakkında bilgi sahibi olmalı ve HPV ile ilişkili enfeksiyon ve kanserleri azaltmak için teknolojideki gelişmeleri takip etmelidir.Papillomavirus infection is a very common and mainly sexually transmitted disease in humans. The development of HPV infection may start from uterine cervix, other lower genital area mucosa and oral mucosa. HPV can cause subclinical or clinical infections. Clinical infections associated with HPV are genital papillomas, skin papillomas, recurrent respiratorial papilomatosis, intraepithelial squamous lesions, cervix, oral cavity and oropharyngeal cancer. Approximately 20% of oral cancers and 60-80% of oropharyngeal cancers are thought to be due to HPV infection. Since the introduction of HPV vaccine in many European countries in 2007, more than 40 countries have launched HPV vaccination in national immunization programs. Physicians responsible for the treatment of oropharyngeal and oral cavity cancer should be knowledgeable about HPV vaccination and should follow developments in technology to reduce HPV-associated infections and cancers

Coexistence of frontal sinus hypoplasia with maxillary sinus hypoplasia: a radiological study

Hizli, Omer/0000-0001-6822-2679WOS: 000426758300012PubMed: 29417280The goal of this study was to determine whether frontal sinus hypoplasia coexists with maxillary sinus hypoplasia. Analyzing paranasal CT scans retrospectively, we included 86 patients who had a hypoplastic maxillary sinus at least on one side and 80 patients with bilateral normal maxillary sinuses (control group). We classified hypoplastic maxillary sinuses using the classification system previously defined by Bolger et al. (Otolaryngol Head Neck Surg 103(5):759-765, 1990). We classified the frontal sinuses as aplastic, hypoplastic, medium-sized, and hyperplastic; as previously defined by Guerram et al. (Am J Phys Anthropol 154(4):621-627, 2014). We compared the presence of frontal sinus hypoplasia using Chi-square test between the groups. The mean age of the maxillary sinus group was 43.2 (range 18-84) years. Of 86 patients, 33 (38.4%) had unilateral and 53 (61.6%) had bilateral maxillary sinus hypoplasia. Of 139 maxillary sinuses totally included, 73 (52.5%) were type 1, 51 (36.7%) were type 2 and 15 (10.8%) were type 3 hypoplastic maxillary sinuses. Of 332 frontal sinuses totally included, 25 (7.5%) were aplastic, 32 (9.6%) were hypoplastic, 172 (51.9%) were medium-sized, and 103 (31%) were hyperplastic. Of 86 patients with a hypoplastic maxillary sinus at least on one side, 29 (33.7%) had a hypoplastic and/or aplastic frontal sinus, while 10 (12.5%) had a hypoplastic and/or aplastic frontal sinus at least on one side in control group. Incidence of frontal sinus hypoplasia and/or aplasia was significantly higher in patients with maxillary sinus hypoplasia compared to the patients with bilaterally normal maxillary sinuses (chi (2) = 10.384, P = 0.001). Maxillary sinus hypoplasia has a significantly higher coexistence with frontal sinus hypoplasia. This study may have an implication for anatomical studies about the development of the paranasal sinuses and paranasal sinus surgery as well as further morphological studies